| 1 | Presentation of the Chief Executive Officer's Report, including the Audited Financial Statements, the Auditors' Opinion, and the Opinion of the Board of Directors for the 2025 fiscal year | Oppose |
| 2 | Approval of the actions carried out by the Board of Directors and Relevant Officers of the Company during the reporting period | Oppose |
| 3 | Proposal for the allocation of results for the fiscal year, including the payment of dividends (MXN 2.0325) | For |
| 4 | Approval of the maximum amount to repurchase of the Company's own shares during fiscal year 2026, and designation of the persons authorised to carry out such transactions | Oppose |
| 5 | Appointment of the members of the Board of Directors and the Chair of the Audit and Corporate Practices Committee, and determination of their respective compensation for the 2026–2027 term | Oppose |
| 6 | Appointment of Special Delegates | For |
| 7 | Drafting, reading, and approval of the minutes of the Meeting | For |
